Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nakanishi A"'
Publikováno v:
Cancer. 103:307-312
BACKGROUND Patients with hepatocellular carcinoma (HCC) who showed early massive disease recurrence due to hematogenous intrahepatic metastasis after curative resection had a poor prognosis. The authors previously reported that Akt phosphorylation wa
Autor:
Seiichiro Yamamoto, Michiie Sakamoto, Yukihiro Nakanishi, Junji Yamamoto, Tomoo Kosuge, Keiichi Okano, Setsuo Hirohashi
Publikováno v:
Cancer. 89:267-275
BACKGROUND The presence of pseudocapsules of liver tumors has been recognized in hepatocellular carcinoma and is known to be a favorable prognostic factor. Although several studies have reported pseudocapsules around metastatic liver tumors, to the a
Autor:
Goro Kajiyama, Hiroshi Aikata, Toshio Nakanishi, Toshinori Ide, Hideki Takaishi, Fumio Shimamoto, Yoshiiku Kawakami, Yasuhiro Nakamura, Shoichi Takahashi, Mikiya Kitamoto
Publikováno v:
Cancer. 88:312-317
BACKGROUND Telomeric repeat amplification protocol using internal telomerase assay standard (ITAS) (conventional TRAP) has detected telomerase activity in various malignant tumors. With conventional TRAP, it is difficult to differentiate quantitative
Autor:
Shoko Suzuki, Hiroyuki Nakanishi, Nobuharu Tamaki, Masayuki Kurosaki, Jun Itakura, Takanori Hosokawa, Yuka Takahashi, Shuya Matsuda, Teiji Kuzuya, Nobuyuki Enomoto, Yasuhiro Asahina, Ken Ueda, Masaru Muraoka, Yuichiro Suzuki, Kaoru Tsuchiya, Namiki Izumi, Toru Nakata, Yutaka Yasui, Takashi Nishimura
Publikováno v:
Cancer
Background A new predictive biomarker for determining prognosis in patients with hepatocellular carcinoma (HCC) who receive sorafenib is required, because achieving a reduction in tumor size with sorafenib is rare, even in patients who have a favorab
Autor:
H, Okuda, T, Nakanishi, K, Takatsu, A, Saito, N, Hayashi, K, Takasaki, K, Takenami, M, Yamamoto, M, Nakano
Publikováno v:
Cancer. 88(3)
Des-gamma-carboxy prothrombin (DCP) is an established marker for hepatocellular carcinoma (HCC), but the conventional enzyme immunoassay (EIA) kit lacks adequate sensitivity. Thus, a revised EIA kit with increased sensitivity has been developed. In t
Autor:
H, Okuda, T, Nakanishi, K, Takatsu, A, Saito, N, Hayashi, K, Watanabe, N, Magario, T, Yokoo, T, Naraki
Publikováno v:
Cancer. 85(4)
Des-gamma-carboxy prothrombin (DCP) is a useful tumor marker for hepatocellular carcinoma (HCC). The conventional enzyme immunoassay (EIA) kit for DCP lacks adequate sensitivity to detect small HCC. Thus, a revised EIA kit for DCP has been developed.
Autor:
Takuji Okusaka, Yukihiro Nakanishi, Hidekazu Nakasuka, Hiroshi Ishii, Shuichi Okada, Susumu Yamasaki, Michiie Sakamoto, Kazuaki Shimada, Masayoshi Yoshimori
Publikováno v:
Cancer. 82(9)
BACKGROUND Percutaneous ethanol injection (PEI) therapy currently is widely used for small hepatocellular carcinoma (HCC). However, only limited information is available regarding needle tract implantation after PEI treatment. METHODS Records of HCC
Autor:
Hiroshi Ikeda, Yoshio Okada, Kenji Jin-no, Nobuyuki Sakai, Shousuke Moriwaki, Sousuke Nakanishi, Taiji Yonei, Masaaki Sotozono, Takao Tsuji
Publikováno v:
Cancer. 73(7)
Background. Malignant transformation of cells is associated with the change in their carbohydrate antigens. Sialyl-Lewisx (SLEX) is a necroinflammation-associated carbohydrate antigen (NICA) of liver cells, because it is newly expressed in chronic in
Publikováno v:
Cancer. 69(1)
The effect of menaquinone-4 (MK-4, vitamin K2) was studied on des-gamma-carboxy prothrombin (DCP or PIVKA-II) levels in three subjects with vitamin K deficiency and five patients with hepatocellular carcinoma (HCC) with positive DCP. The half-life of
Autor:
Tsugio Kitamura, Sachiko Tanaka, Isaburo Fujimoto, Tomohiko Hiyama, Katsumi Nakanishi, Shigeru Okuda, Hideo Yamazaki
Publikováno v:
Cancer. 66(10)
Periodic checkup by ultrasonography was conducted on patients with chronic liver diseases for early detection of hepatocellular carcinoma. in 19 months, a total of 2004 examinations were performed on a total of 660 cases (179 cases with liver cirrhos